martes, 26 de noviembre de 2019

FDA Stakeholder Update - November 26, 2019



Consumer Update

 
You may have noticed that cannabidiol (CBD) seems to be available almost everywhere, and marketed as a variety of products including drugs, food, dietary supplements, cosmetics, and animal health products.
  • The FDA has approved only one CBD product, a prescription drug product to treat two rare, severe forms of epilepsy.
  • It is currently illegal to market CBD by adding it to a food or labeling it as a dietary supplement.
  • The FDA has seen only limited data about CBD safety and these data point to real risks that need to be considered before taking CBD for any reason.
  • Some CBD products are being marketed with unproven medical claims and are of unknown quality.
  • The FDA will continue to update the public as it learns more about CBD.

No hay comentarios: